BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

343 related articles for article (PubMed ID: 31400633)

  • 21. An MRI brain atrophy and lesion index to assess the progression of structural changes in Alzheimer's disease, mild cognitive impairment, and normal aging: a follow-up study.
    Zhang N; Song X; Zhang Y; Chen W; D'Arcy RC; Darvesh S; Fisk JD; Rockwood K;
    J Alzheimers Dis; 2011; 26 Suppl 3():359-67. PubMed ID: 21971475
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A novel joint HCPMMP method for automatically classifying Alzheimer's and different stage MCI patients.
    Sheng J; Wang B; Zhang Q; Liu Q; Ma Y; Liu W; Shao M; Chen B
    Behav Brain Res; 2019 Jun; 365():210-221. PubMed ID: 30836158
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Network localization of clinical, cognitive, and neuropsychiatric symptoms in Alzheimer's disease.
    Tetreault AM; Phan T; Orlando D; Lyu I; Kang H; Landman B; Darby RR;
    Brain; 2020 Apr; 143(4):1249-1260. PubMed ID: 32176777
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lower Serum Calcium as a Potentially Associated Factor for Conversion of Mild Cognitive Impairment to Early Alzheimer's Disease in the Japanese Alzheimer's Disease Neuroimaging Initiative.
    Sato K; Mano T; Ihara R; Suzuki K; Tomita N; Arai H; Ishii K; Senda M; Ito K; Ikeuchi T; Kuwano R; Matsuda H; Iwatsubo T; Toda T; Iwata A;
    J Alzheimers Dis; 2019; 68(2):777-788. PubMed ID: 30814351
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impacts of CD33 Genetic Variations on the Atrophy Rates of Hippocampus and Parahippocampal Gyrus in Normal Aging and Mild Cognitive Impairment.
    Wang WY; Liu Y; Wang HF; Tan L; Sun FR; Tan MS; Tan CC; Jiang T; Tan L; Yu JT;
    Mol Neurobiol; 2017 Mar; 54(2):1111-1118. PubMed ID: 26803496
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Following the Spreading of Brain Structural Changes in Alzheimer's Disease: A Longitudinal, Multimodal MRI Study.
    Weiler M; Agosta F; Canu E; Copetti M; Magnani G; Marcone A; Pagani E; Balthazar ML; Comi G; Falini A; Filippi M
    J Alzheimers Dis; 2015; 47(4):995-1007. PubMed ID: 26401778
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A novel method for PET connectomics guided by fibre-tracking MRI: Application to Alzheimer's disease.
    Sun Z; Naismith SL; Meikle S; Calamante F;
    Hum Brain Mapp; 2024 Mar; 45(4):e26659. PubMed ID: 38491564
    [TBL] [Abstract][Full Text] [Related]  

  • 28. AddNeuroMed and ADNI: similar patterns of Alzheimer's atrophy and automated MRI classification accuracy in Europe and North America.
    Westman E; Simmons A; Muehlboeck JS; Mecocci P; Vellas B; Tsolaki M; Kłoszewska I; Soininen H; Weiner MW; Lovestone S; Spenger C; Wahlund LO; ;
    Neuroimage; 2011 Oct; 58(3):818-28. PubMed ID: 21763442
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Predicting the progression of mild cognitive impairment to Alzheimer's disease by longitudinal magnetic resonance imaging-based dictionary learning.
    Lin Y; Huang K; Xu H; Qiao Z; Cai S; Wang Y; Huang L;
    Clin Neurophysiol; 2020 Oct; 131(10):2429-2439. PubMed ID: 32829290
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Structural and functional connectional fingerprints in mild cognitive impairment and Alzheimer's disease patients.
    Son SJ; Kim J; Park H
    PLoS One; 2017; 12(3):e0173426. PubMed ID: 28333946
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Risk estimation before progression to mild cognitive impairment and Alzheimer's disease: an AD resemblance atrophy index.
    Zhao L; Luo Y; Lew D; Liu W; Au L; Mok V; Shi L;
    Aging (Albany NY); 2019 Aug; 11(16):6217-6236. PubMed ID: 31467257
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Structural Neuroimaging Genetics Interactions in Alzheimer's Disease.
    Moon SW; Dinov ID; Kim J; Zamanyan A; Hobel S; Thompson PM; Toga AW
    J Alzheimers Dis; 2015; 48(4):1051-63. PubMed ID: 26444770
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Basal forebrain atrophy correlates with amyloid β burden in Alzheimer's disease.
    Kerbler GM; Fripp J; Rowe CC; Villemagne VL; Salvado O; Rose S; Coulson EJ;
    Neuroimage Clin; 2015; 7():105-13. PubMed ID: 25610772
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Plasma clusterin concentration is associated with longitudinal brain atrophy in mild cognitive impairment.
    Thambisetty M; An Y; Kinsey A; Koka D; Saleem M; Güntert A; Kraut M; Ferrucci L; Davatzikos C; Lovestone S; Resnick SM
    Neuroimage; 2012 Jan; 59(1):212-7. PubMed ID: 21824521
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Changes in functional and structural brain connectome along the Alzheimer's disease continuum.
    Filippi M; Basaia S; Canu E; Imperiale F; Magnani G; Falautano M; Comi G; Falini A; Agosta F
    Mol Psychiatry; 2020 Jan; 25(1):230-239. PubMed ID: 29743583
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Measuring Global Brain Atrophy with the Brain Volume/Cerebrospinal Fluid Index: Normative Values, Cut-Offs and Clinical Associations.
    Orellana C; Ferreira D; Muehlboeck JS; Mecocci P; Vellas B; Tsolaki M; Kłoszewska I; Soininen H; Lovestone S; Simmons A; Wahlund LO; Westman E;
    Neurodegener Dis; 2016; 16(1-2):77-86. PubMed ID: 26726737
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A parameter-efficient deep learning approach to predict conversion from mild cognitive impairment to Alzheimer's disease.
    Spasov S; Passamonti L; Duggento A; Liò P; Toschi N;
    Neuroimage; 2019 Apr; 189():276-287. PubMed ID: 30654174
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hippocampal volume change measurement: quantitative assessment of the reproducibility of expert manual outlining and the automated methods FreeSurfer and FIRST.
    Mulder ER; de Jong RA; Knol DL; van Schijndel RA; Cover KS; Visser PJ; Barkhof F; Vrenken H;
    Neuroimage; 2014 May; 92():169-81. PubMed ID: 24521851
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of HMGCR genetic variation on neuroimaging biomarkers in healthy, mild cognitive impairment and Alzheimer's disease cohorts.
    Cao L; Wang HF; Tan L; Sun FR; Tan MS; Tan CC; Jiang T; Yu JT; Tan L;
    Oncotarget; 2016 Mar; 7(12):13319-27. PubMed ID: 26950278
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cerebral atrophy in mild cognitive impairment and Alzheimer disease: rates and acceleration.
    Leung KK; Bartlett JW; Barnes J; Manning EN; Ourselin S; Fox NC;
    Neurology; 2013 Feb; 80(7):648-54. PubMed ID: 23303849
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.